CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Amicogen Inc Company Snapshot
Amicogen Inc operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Amicogen Inc with three other companies in this sector in KOREA (SOUTH) : CKD Bio Corp (2020 sales of 124.60 billion Korean Won [US$111.39 million] of which 33% was Potassium Clavulanate), Samil Pharmaceutical Co., Ltd. (123.00 billion Korean Won [US$109.96 million] ), and Hwail Pharmaceutical Company Limited (123.61 billion Korean Won [US$110.51 million] ).

Sales Analysis. During the first quarter of 2021, sales at Amicogen Inc totalled 30.65 billion Korean Won . This is an increase of 21.5% from the 25.23 billion Korean Won in sales at the company during the first quarter of 2020. There appears to be at least some degree of seasonality in the sales at Amicogen Inc: during 7 of the previous 8 years, sales were highest during the fourth quarter. The exception to this was during 2018, when the first quarter was the best quarter, accounting for 31% of sales (during that same year, the fourth quarter accounted for 21% of sales). Amicogen Inc reported sales of 115.86 billion Korean Won (US$103.58 million) for the year ending December of 2020. This represents a very small increase of 0.6% versus 2019, when the company's sales were 115.18 billion Korean Won . Sales at Amicogen Inc have increased during each of the previous five years (and since 2015, sales have increased a total of 257%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Amicogen Inc
  Stock Performance Chart for Amicogen Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): 36,900
(Figures in Korean Won )
1 Week 3.1%   13 Weeks -4.4%  
4 Weeks 19.6%   52 Weeks 12.7%  
 
Amicogen Inc Key Data:
  Ticker: 092040 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2020 Sales 115,856,068,707
(Year Ending Jan 2021).
Employees: 113
  Currency: Korean Won Market Cap: 701,630,658,900
  Fiscal Yr Ends: December Shares Outstanding: 19,014,381
  Share Type: Ordniary Closely Held Shares: 3,156,197
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.